Sono-Tek Corporation — FY2013 Form 10-K
Business context and reporting period. Sono-Tek develops and sells ultrasonic spray-coating equipment for electronics, advanced energy, medical devices, glass, textiles, and food applications. This filing covers the fiscal year ended February 28, 2013, compared with the year ended February 29, 2012; it is not a standalone Q4 report.
Financial performance and liquidity
| Metric | FY2013 | FY2012 |
|---|---|---|
| Revenue | $9.542 million | $12.053 million |
| Gross profit / gross margin | $4.532 million / 47.5% | $6.166 million / 51.2% |
| Operating income | $151,000 | $1.261 million |
| Net income / diluted EPS | $132,000 / $0.01 | $1.432 million / $0.09 |
| Cash from operations | $611,000 | $1.192 million |
- Revenue fell 21%; net income declined about 91%. Gross margin contracted by approximately 3.7 percentage points. Operating and net margins were approximately 1.6% and 1.4%, respectively, versus 10.5% and 11.9% in FY2012.
- Operating cash flow was supported by a $723,000 inventory reduction; receivables increased $181,000, while accounts payable, accrued expenses, and customer deposits declined.
- Cash and cash equivalents were $1.941 million, and marketable securities were $976,000, at year-end. Cash declined $591,000, while securities increased $722,000, largely reflecting purchases of investments.
- Working capital was $4.680 million and the reported current ratio was 5.3:1. Total debt was $2.113 million, including a $1.973 million mortgage at 5.5% and $141,000 equipment loan at 2.12%. The $750,000 revolving credit line had no outstanding borrowings.
- Stockholders’ equity increased to $5.992 million from $5.808 million. No cash dividends have been paid.
Material changes and management commentary
- Management attributed lower sales to solar-industry overcapacity and reduced government incentives, as well as slower purchasing by other customers and segments. Sales associated directly or indirectly with government funding fell to about $1.7 million from $2.8 million.
- Foreign sales decreased to $5.157 million, or 54% of revenue, from $7.385 million, or 62%. European sales fell 55%; Asian sales fell 16%; U.S. sales fell 5%.
- Sales declined across most product categories, including nozzles and generators, fluxers, stent-coating, XYZ, WideTrack, and Hypersonic units; Servo unit sales increased.
- Research and product development expense decreased to $894,000 from $1.129 million. Marketing and selling expense and general and administrative expense also declined.
- The industrial park rental operation reported a $177,000 net loss, compared with a $156,000 loss. A tenant receiving reduced rent was expected to vacate in May 2013; the company reported signing a five-year lease for 10,000 square feet in April 2013.
Outlook, risks, and unusual items
- No quantified revenue or earnings guidance is provided. Management described its broader product, industry, and geographic diversification as a foundation for future growth and improved profitability.
- Forward-looking risks identified include economic and business conditions, competition, regulatory and technological developments, new-product development and acceptance, financing adequacy, capacity additions, patent protection, and achieving higher sales and continued profitability.
- The company depends in part on government-funded projects and international markets. Three customers represented 35.5% of year-end accounts receivable, although no single customer exceeded 4.6% of annual sales.
- FY2013 included a $74,000 income-tax benefit, compared with a $291,000 benefit in FY2012. No net operating loss carryforwards remained; $100,000 of research and development tax credits were carried forward.
- The filing reports no material commitments or contingencies, no legal proceedings, and no off-balance-sheet arrangements. Management concluded disclosure controls and internal control over financial reporting were effective; the auditor issued an unqualified opinion.
Important facts for investors to verify
- Whether revenue and margins recover after the sharp decline, particularly in solar-related and government-supported demand.
- Whether the new industrial-park tenant occupies the space as expected and improves the property’s cash contribution.
- The quality and liquidity of marketable securities, and the cash impact of future equipment, patent, and debt expenditures.
- Customer receivable concentration, international sales exposure, and the company’s reliance on customer deposits or bank-issued letters of credit.
- The effect of the FY2013 option grants and cancellations on future dilution; 1,322,718 options were outstanding at year-end.